Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

139
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
139
Bipolar Disorder01:30

Bipolar Disorder

58
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
58
Drug Therapy01:28

Drug Therapy

39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
39
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

110
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
110
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

28
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
28
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Essential Information About Chronobiology and Chronotherapy for the Optimal Care of People With Bipolar Disorders: An Expert Consensus.

Bipolar disorders·2026
Same author

Family History and Solar Insolation in Bipolar I Disorder.

Acta psychiatrica Scandinavica·2026
Same author

Rethinking Schizophrenia: Optimizing Care Pathways in Europe from the First Episode of Psychosis to Long-Term Care.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Essential information about chronobiology and chronotherapy for the optimal care of people with bipolar disorders: an international expert consensus.

medRxiv : the preprint server for health sciences·2025
Same author

The Mechanisms of Lithium Action: The Old and New Findings.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study.

Translational psychiatry·2024

Related Experiment Video

Updated: Jun 11, 2025

Developing a Rat Model for Bipolar Disorder
04:44

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

222

What Patients with Bipolar Disorder Need to Know about Lithium.

Robert M Post1, Janusz K Rybakowski2

  • 1Bipolar Collaborative Network, Chevy Chase, MD 20815, USA.

Pharmaceuticals (Basel, Switzerland)
|September 28, 2024
PubMed
Summary

Lithium is the best first-line treatment for bipolar disorder (BD), but its use is low due to poor reputation. Educating patients about lithium

Keywords:
bipolar disorderlithiumtherapeutics

More Related Videos

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

79.8K
Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

9.7K

Related Experiment Videos

Last Updated: Jun 11, 2025

Developing a Rat Model for Bipolar Disorder
04:44

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

222
The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

79.8K
Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

9.7K

Area of Science:

  • Psychiatry and Pharmacology

Background:

  • Lithium is the gold standard first-line treatment for bipolar disorder (BD).
  • Current prescription rates for lithium in BD patients are notably low, particularly in the United States.
  • A significant gap exists in patient and prescriber awareness regarding lithium's benefits and risks.

Purpose of the Study:

  • To advocate for increased patient education on the efficacy and characteristics of lithium for bipolar disorder.
  • To address the underappreciation of lithium's unique therapeutic assets and the overestimation of its side effect profile.
  • To propose a rebranding and renaming strategy for lithium to improve its perception and clinical application.

Main Methods:

  • Review of existing literature on lithium's efficacy and side effect profile in bipolar disorder.
  • Analysis of factors contributing to the low adoption rates of lithium.
  • Development of a communication strategy to reframe lithium's public and professional image.

Main Results:

  • Lithium possesses unique therapeutic advantages for bipolar disorder that are frequently underestimated.
  • The perceived risks and side effects associated with lithium are often exaggerated compared to actual clinical data.
  • A negative public and professional reputation hinders the appropriate and timely use of lithium.

Conclusions:

  • There is a critical need to enhance patient and physician understanding of lithium's benefits for bipolar disorder.
  • Revising the narrative and terminology surrounding lithium is essential for improving its utilization.
  • Implementing a rebranding initiative could significantly increase the appropriate application of lithium in BD treatment.